SPAC806.06c Antibody

What is SPAC806.06c and why is it significant in research?

SPAC806.06c is a gene locus in Schizosaccharomyces pombe (fission yeast) identified in genomic databases including KEGG (spo:SPAC806.06c) and STRING (4896.SPAC806.06c.1) . While specific published functional characterization is limited, antibodies against this target enable researchers to investigate its protein expression patterns, cellular localization, and potential functions in yeast cellular processes. S. pombe serves as an important model organism for studying fundamental eukaryotic cellular mechanisms, making tools for investigating its proteome valuable for comparative genomics and evolutionary biology research.

What validation methods should be employed for SPAC806.06c antibodies?

Validation of SPAC806.06c antibodies should follow a multi-method approach similar to those used for other research antibodies. Researchers should:

• Perform Western blotting with positive and negative controls (wild-type vs. SPAC806.06c knockout strains)

• Conduct immunoprecipitation followed by mass spectrometry to confirm target specificity

• Analyze antibody performance in immunofluorescence microscopy against tagged variants

• Evaluate cross-reactivity against related proteins using sequence alignment and experimental testing

Similar to methodologies used for other antibodies, researchers should assess epitope specificity through ELISA testing against recombinant protein and peptide fragments .

How should researchers determine the optimal working concentration for SPAC806.06c antibody?

Determining the optimal working concentration requires systematic titration experiments across different applications:

For each application, researchers should prepare a dilution series and evaluate antibody performance using positive and negative controls. The optimization process should follow similar methodological approaches to those used for other antibodies in research settings , focusing on maximizing specific binding while minimizing background.

What are the recommended protocols for using SPAC806.06c antibody in immunoprecipitation experiments?

For immunoprecipitation of SPAC806.06c protein:

• Harvest and lyse S. pombe cells in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, and protease inhibitors

• Clear lysate by centrifugation (14,000 × g, 10 min, 4°C)

• Pre-clear with protein A/G beads for 1 hour at 4°C

• Incubate cleared lysate with SPAC806.06c antibody (2-5 μg per 1 mg of protein) overnight at 4°C

• Add protein A/G beads and incubate for 2-3 hours at 4°C

• Wash beads 4-5 times with lysis buffer

• Elute bound proteins with SDS sample buffer for western blot analysis

This protocol follows methodological principles similar to those used for immunoprecipitation of other proteins in research settings , with specific optimizations for yeast cell lysis conditions.

How can SPAC806.06c antibody be used for studying protein-protein interactions?

SPAC806.06c antibody can facilitate the study of protein-protein interactions through several approaches:

• Co-immunoprecipitation (Co-IP): Perform immunoprecipitation as described above, then analyze co-precipitated proteins by mass spectrometry or western blotting with antibodies against suspected interaction partners.

• Proximity Ligation Assay (PLA): Use SPAC806.06c antibody in combination with antibodies against potential interaction partners to visualize protein complexes in situ.

• ChIP-seq applications: If SPAC806.06c is involved in DNA-binding or chromatin-associated complexes, the antibody can be used in chromatin immunoprecipitation followed by sequencing.

Each method requires specific controls similar to those used in virus capture competition assays described for other research antibodies , including isotype controls and validation using known interacting and non-interacting proteins.

What are the technical considerations for using SPAC806.06c antibody in flow cytometry?

When using SPAC806.06c antibody for flow cytometry:

• Cell preparation: S. pombe cells require special preparation (cell wall digestion with zymolyase or lysing enzymes) to ensure antibody accessibility

• Fixation and permeabilization: Optimize fixation (4% paraformaldehyde) and permeabilization (0.1-0.5% Triton X-100) conditions

• Antibody concentration: Typically higher concentrations (1-2 μg per 10⁶ cells) are needed compared to mammalian cells

• Controls: Include:

  • Unstained cells

  • Secondary antibody only

  • Isotype control

  • Positive control (if available, such as tagged SPAC806.06c)

  • Negative control (SPAC806.06c knockout strain)

These technical considerations are similar to those employed for flow cytometry protocols using other antibodies , with specific adaptations for yeast cells.

How can researchers address inconsistent Western blot results with SPAC806.06c antibody?

Inconsistent Western blot results may stem from several factors:

• Protein extraction efficiency: S. pombe cell walls can interfere with protein extraction. Optimize lysis methods using mechanical disruption (glass beads) combined with detergent-based buffers.

• Denaturation conditions: Test different denaturation temperatures (65°C, 95°C) and times (5, 10 min).

• Epitope accessibility: If the antibody targets a conformational epitope, adjust reducing agent concentration in sample buffer.

• Transfer conditions: Optimize transfer parameters for SPAC806.06c's molecular weight:

  • For proteins <50 kDa: 100V for 1 hour

  • For proteins >50 kDa: 30V overnight at 4°C

• Blocking conditions: Compare different blocking agents (5% milk, 5% BSA) and their impact on background.

These troubleshooting approaches follow principles used for other research antibodies while addressing specific challenges of working with yeast proteins.

What strategies can improve SPAC806.06c antibody specificity in complex experimental systems?

To enhance specificity in complex systems:

• Pre-absorption: Incubate the antibody with lysate from SPAC806.06c knockout strains to remove antibodies that bind non-specifically.

• Epitope competition: Pre-incubate with recombinant SPAC806.06c peptide fragments to confirm binding specificity, similar to virus capture competition assays .

• Immunodepletion studies: Sequentially deplete lysates with the antibody and assess residual target protein.

• Cross-linking approaches: Use chemical cross-linkers before immunoprecipitation to stabilize transient interactions.

• Tandem purification: Combine antibody-based purification with other tagging systems for increased specificity.

Each approach requires careful control experiments to validate improved specificity, similar to methodologies used to characterize other research antibodies .

How can SPAC806.06c antibody be used in quantitative proteomics research?

In quantitative proteomics, SPAC806.06c antibody can be employed in several advanced approaches:

• Immuno-MRM (Multiple Reaction Monitoring): Use antibody-based enrichment followed by targeted mass spectrometry for absolute quantification.

• SILAC (Stable Isotope Labeling with Amino acids in Cell culture): Combine with antibody pulldown to study differential interactions under various conditions.

• TMT (Tandem Mass Tag) labeling: Use with immunoprecipitation to measure dynamic changes in SPAC806.06c complexes.

• Proximity-dependent labeling: Conjugate the antibody to enzymes like BioID or APEX2 for vicinity-based proteomics.

Quantitative analysis parameters should be carefully established using standard curves with recombinant protein standards, following methodological principles similar to those used in ELISA and other quantitative immunoassays .

How should researchers integrate SPAC806.06c antibody data with other omics datasets?

Integration strategies include:

• Correlation analysis: Compare protein expression data from SPAC806.06c antibody studies with transcriptomic data to identify post-transcriptional regulation.

• Network analysis: Place SPAC806.06c interaction partners identified through antibody-based studies within protein-protein interaction networks (building on STRING database information) .

• Pathway enrichment: Analyze immunoprecipitation-mass spectrometry (IP-MS) results using tools like KEGG or GO term enrichment.

• Cross-species comparative analysis: Compare SPAC806.06c localization and interaction data with orthologous proteins in related species.

• Multi-condition differential analysis: Compare SPAC806.06c complexes under various stress conditions or genetic backgrounds.

These integration approaches borrow methodological principles from systems biology analysis used in antibody-based research of other proteins .

What are the considerations for designing epitope tagging experiments to complement SPAC806.06c antibody studies?

When designing epitope tagging experiments:

• Tag position impact: Evaluate both N- and C-terminal tags to determine which least affects protein function.

• Tag selection criteria:

  • Size: Smaller tags (FLAG, V5, HA) often cause less functional interference

  • Detection sensitivity: Compare commercial antibody sensitivities across tags

  • Application compatibility: Ensure tag antibodies work in your specific applications

• Validation experiments:

  • Functional complementation of knockout strain

  • Co-localization studies with SPAC806.06c antibody

  • Comparative immunoprecipitation between tagged protein and endogenous protein using SPAC806.06c antibody

• Quantitative comparisons: Use both approaches in parallel to validate experimental findings, following methodological principles similar to those used for antibody validation in research settings .

How can researchers assess potential cross-reactivity of SPAC806.06c antibody with human proteins in heterologous expression systems?

To assess potential cross-reactivity:

• Sequence homology analysis: Perform BLAST analysis of the SPAC806.06c epitope against the human proteome.

• Western blot testing: Run parallel western blots with:

  • S. pombe lysate (positive control)

  • Human cell lysates from multiple tissue origins

  • Human cells transfected with SPAC806.06c expression vector (positive control)

• Immunofluorescence co-localization: In cells expressing fluorescently-tagged SPAC806.06c, compare antibody staining patterns with tag fluorescence.

• Mass spectrometry validation: Perform immunoprecipitation from human cells expressing SPAC806.06c and analyze precipitated proteins to identify potential cross-reactive proteins.

These approaches build on methodological principles used for assessing polyreactivity in antibody research, similar to ELISA-based polyreactivity testing described for other antibodies .

What emerging technologies might enhance SPAC806.06c antibody research applications?

Emerging technologies with potential applications include:

• Single-cell proteomics: Adapting SPAC806.06c antibody for single-cell western blot or CyTOF analysis to study cell-to-cell variation.

• Super-resolution microscopy: Optimizing SPAC806.06c antibody labeling for techniques like STORM or PALM to visualize subcellular localization at nanometer resolution.

• Microfluidic antibody capture: Developing microfluidic platforms for high-throughput SPAC806.06c interaction studies.

• Cryo-EM structural studies: Using SPAC806.06c antibody fragments to stabilize protein complexes for structural determination.

• CRISPR-based genomic tagging: Combining endogenous tagging approaches with antibody detection for studying native protein complexes.

These emerging approaches follow methodological evolutions seen in other areas of antibody research, particularly in structural biology and proteomics applications .

How should researchers evaluate conflicting data between different lots of SPAC806.06c antibody?

To evaluate conflicting data between antibody lots:

• Documentation and tracking: Maintain detailed records of lot numbers, validation data, and experimental conditions.

• Side-by-side testing: Perform parallel experiments with multiple lots under identical conditions.

• Epitope mapping: Determine if different lots recognize distinct epitopes that might be differentially accessible in certain experimental conditions.

• Cross-validation: Verify findings using orthogonal methods (e.g., epitope tagging, mass spectrometry).

• Statistical analysis: Implement robust statistical methods to quantify lot-to-lot variation and determine if differences are significant.